TRIPS Agreement and access to medicines

This procedure concerns the TRIPS Agreement, which governs intellectual property rights for trade. It examines how these rules impact access to essential medicines, particularly in developing countries, and explores potential flexibilities within the agreement.

It affects pharmaceutical companies, governments, and patients worldwide. The discussion aims to balance intellectual property protection with public health needs, ensuring affordable access to medicines.